These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21881568)

  • 1. Activation of nociceptin/orphanin FQ peptide receptors disrupts visual but not auditory sensorimotor gating in BALB/cByJ mice: comparison to dopamine receptor agonists.
    Ces A; Reiss D; Walter O; Wichmann J; Prinssen EP; Kieffer BL; Ouagazzal AM
    Neuropsychopharmacology; 2012 Jan; 37(2):378-89. PubMed ID: 21881568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of the non-peptide nociceptin receptor agonist, Ro64-6198 in Chinese hamster ovary cells expressing recombinant human nociceptin receptors.
    Hashiba E; Lambert DG; Jenck F; Wichmann J; Smith G
    Life Sci; 2002 Mar; 70(15):1719-25. PubMed ID: 12002517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neurosteroidogenic enzyme 5α-reductase modulates the role of D1 dopamine receptors in rat sensorimotor gating.
    Frau R; Mosher LJ; Bini V; Pillolla G; Pes R; Saba P; Fanni S; Devoto P; Bortolato M
    Psychoneuroendocrinology; 2016 Jan; 63():59-67. PubMed ID: 26415119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of D3/D2 dopamine receptor agonists and antagonists on prepulse inhibition of acoustic startle in the rat.
    Caine SB; Geyer MA; Swerdlow NR
    Neuropsychopharmacology; 1995 Apr; 12(2):139-45. PubMed ID: 7779242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nociceptin/orphanin FQ receptors modulate the discriminative stimulus effects of oxycodone in C57BL/6 mice.
    Walentiny DM; Wiebelhaus JM; Beardsley PM
    Drug Alcohol Depend; 2018 Jun; 187():335-342. PubMed ID: 29705547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
    Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
    Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kappa opioid receptor activation disrupts prepulse inhibition of the acoustic startle in rats.
    Bortolato M; Aru GN; Frau R; Orrù M; Fà M; Manunta M; Puddu M; Mereu G; Gessa GL
    Biol Psychiatry; 2005 Jun; 57(12):1550-8. PubMed ID: 15953492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous nociceptin/orphanin FQ (N/OFQ) contributes to haloperidol-induced changes of nigral amino acid transmission and parkinsonism: a combined microdialysis and behavioral study in naïve and nociceptin/orphanin FQ receptor knockout mice.
    Mabrouk OS; Marti M; Morari M
    Neuroscience; 2010 Mar; 166(1):40-8. PubMed ID: 20006677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of startle.
    Keith VA; Mansbach RS; Geyer MA
    Biol Psychiatry; 1991 Sep; 30(6):557-66. PubMed ID: 1834231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of atomoxetine and methylphenidate on the prepulse inhibition of the acoustic startle response in mice.
    Woo H; Park SJ; Lee Y; Kwon G; Gao Q; Lee HE; Ahn YJ; Shin CY; Cheong JH; Ryu JH
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():206-15. PubMed ID: 24953433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine D1 rather than D2 receptor agonists disrupt prepulse inhibition of startle in mice.
    Ralph-Williams RJ; Lehmann-Masten V; Geyer MA
    Neuropsychopharmacology; 2003 Jan; 28(1):108-18. PubMed ID: 12496946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rat strain differences in the ability to disrupt sensorimotor gating are limited to the dopaminergic system, specific to prepulse inhibition, and unrelated to changes in startle amplitude or nucleus accumbens dopamine receptor sensitivity.
    Kinney GG; Wilkinson LO; Saywell KL; Tricklebank MD
    J Neurosci; 1999 Jul; 19(13):5644-53. PubMed ID: 10377370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of D1, but not D2 receptors potentiates dizocilpine-mediated disruption of prepulse inhibition of the startle.
    Bortolato M; Aru GN; Fà M; Frau R; Orrù M; Salis P; Casti A; Luckey GC; Mereu G; Gessa GL
    Neuropsychopharmacology; 2005 Mar; 30(3):561-74. PubMed ID: 15328529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of 5α-reductase attenuates behavioral effects of D1-, but not D2-like receptor agonists in C57BL/6 mice.
    Frau R; Pillolla G; Bini V; Tambaro S; Devoto P; Bortolato M
    Psychoneuroendocrinology; 2013 Apr; 38(4):542-51. PubMed ID: 22877998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nociceptin/orphanin FQ receptor activation attenuates antinociception induced by mixed nociceptin/orphanin FQ/mu-opioid receptor agonists.
    Khroyan TV; Polgar WE; Jiang F; Zaveri NT; Toll L
    J Pharmacol Exp Ther; 2009 Dec; 331(3):946-53. PubMed ID: 19713488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of nociceptin/orphanin FQ receptor (NOP) agonist, Ro64-6198, on reactivity to acute pain in mice: comparison to morphine.
    Reiss D; Wichmann J; Tekeshima H; Kieffer BL; Ouagazzal AM
    Eur J Pharmacol; 2008 Jan; 579(1-3):141-8. PubMed ID: 18031727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ro 64-6198 [(1S,3aS)-8-(2,3,3a,4,5,6-Hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one] acts differently from nociceptin/orphanin FQ in rat periaqueductal gray slices.
    Chiou LC; Chuang KC; Wichmann J; Adam G
    J Pharmacol Exp Ther; 2004 Nov; 311(2):645-51. PubMed ID: 15254141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apomorphine-induced prepulse inhibition disruption is associated with a paradoxical enhancement of prepulse stimulus reactivity.
    Yee BK; Russig H; Feldon J
    Neuropsychopharmacology; 2004 Feb; 29(2):240-8. PubMed ID: 14666120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GPR88 in A
    Meirsman AC; de Kerchove d'Exaerde A; Kieffer BL; Ouagazzal AM
    Eur J Neurosci; 2017 Aug; 46(4):2026-2034. PubMed ID: 28700108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral effects of a synthetic agonist selective for nociceptin/orphanin FQ peptide receptors in monkeys.
    Ko MC; Woods JH; Fantegrossi WE; Galuska CM; Wichmann J; Prinssen EP
    Neuropsychopharmacology; 2009 Aug; 34(9):2088-96. PubMed ID: 19279568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.